Pharma
Adragos Pharma Expands Global Reach with Acquisition of Swiss CDMO Baccinex
Adragos Pharma, Baccinex, CDMO, aseptic fill-finish, sterile drug production, pharmaceutical manufacturing
Enveda Secures $130 Million in Funding for Innovative Therapies in Inflammation, Obesity, and Beyond
Enveda, Microsoft-backed, $130M funding, Inflammation & Immunology (I&I), obesity, biotech, pharma, drug development
Pharmaceutical Industry’s Digital Transformation Halted by Persistent Skills Shortage
Digital transformation in pharma, Skills shortage, Pharmaceutical industry challenges, Talent acquisition, Digital skills gap
Nxera Pharma and Antiverse Collaborate to Develop Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
Nxera Pharma, Antiverse, GPCR-targeted antibodies, Generative AI, Antibody therapeutics, Biopharma collaboration
Novo Nordisk and Ascendis Pharma Collaborate on Groundbreaking Once-Monthly GLP-1 Treatment for Obesity and Type 2 Diabetes
Novo Nordisk, Ascendis Pharma, GLP-1 receptor agonist, once-monthly treatment, obesity, type 2 diabetes, metabolic diseases, cardiovascular therapies, TransCon technology.
Novo Nordisk Secures $285 Million Biobucks Deal with Ascendis Pharma for Monthly GLP-1 Agonist Development
Novo Nordisk, Ascendis Pharma, GLP-1 agonist, biobucks deal, pharmaceutical development
ESSA Pharma Terminates Masofaniten Development After Phase 2 Trial Failure in Prostate Cancer
ESSA Pharma, Masofaniten, Prostate Cancer, Phase 2 Trial, Enzalutamide, Xtandi, Clinical Trial Termination
Leo Pharma Announces Major Restructuring with Up to 250 Layoffs and Relocations
Leo Pharma, layoffs, relocations, restructuring, biopharma, job cuts
Astellas Launches First Direct-to-Consumer Campaign for IZERVAY, Highlighting Its Potential to Slow Geographic Atrophy Progression
IZERVAY, geographic atrophy, age-related macular degeneration, direct-to-consumer campaign, Astellas Pharma
Biopharma Layoff Tracker 2024: Ongoing Industry Downsizing
Biopharma layoffs, 2024 layoffs, pharmaceutical industry downsizing, biotech job cuts, pharma restructuring